Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects (INSIGHT)
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
Sponsor: Biodesix, Inc.
A observational or N/A phase clinical study on Non-Small Cell Lung Cancer, this trial is ongoing. The trial is conducted by Biodesix, Inc. and has accumulated 10 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Oct 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2023 — Mar 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Mar 2021 — Jan 2023 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biodesix, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .